SCHEMBL6922503

SCHEMBL6922503

CC(=O)NCCc1c[nH]c2ccc(-c3ccccc3)cc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.70
BLM P54132 3/20 0.70
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
LMNA P02545 1/20 0.70
PKM P14618 1/20 0.70
TSHR P16473 1/20 0.70
CYP2C19 P33261 1/20 0.70
MTNR1A P48039 12/20 0.69
MTNR1B P49286 12/20 0.69
NOTUM Q6P988 3/20 0.69
KDM4E B2RXH2 2/20 0.69
ALDH1A1 P00352 2/20 0.69
CYP3A4 P08684 2/20 0.69
CYP2D6 P10635 2/20 0.69
HPGD P15428 2/20 0.69
MAPT P10636 1/20 0.69
IDO1 P14902 1/20 0.69
SPR P35270 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921195 0.87 MTNR1A (0.82) CYP1A2BLMMEN1KMT2AMTNR1A
SCHEMBL7334188 0.84 TRPV1 (0.65) MTNR1AMTNR1BIDO1TRPV1FAAH
SCHEMBL7022005 0.83 MTNR1A (0.65) CYP1A2BLMMEN1KMT2ALMNA
SCHEMBL6923141 0.83 ICMT (0.67) CYP1A2BLMMEN1KMT2ALMNA
SCHEMBL1774144 0.83 CYP1A2 (0.67) CYP1A2BLMMEN1KMT2ALMNA
SCHEMBL7330504 0.83 KDM4E (0.66) MEN1KMT2ALMNAKDM4EALDH1A1
Nb-Acetyltryptamine SCHEMBL468850 0.83 MEN1 (1.00) CYP1A2BLMMEN1KMT2ALMNA
SCHEMBL7015300 0.82 MTNR1A (0.62) CYP1A2BLMMEN1KMT2ALMNA
SCHEMBL31543720 0.82 MTNR1A (0.72) CYP1A2BLMMEN1KMT2ALMNA
SCHEMBL8285865 0.82 MTNR1A (0.72) CYP1A2BLMMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004085392-A1 MELATONIN DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL DYSFUNCTIONS FAUST PHARMACEUTICALS (FR) 2004-10-07 WO disclosed